Mangels Valuation Multiples

Mangels is valued at $4M as of September 2026, a 0.7x revenue multiple. In the last fiscal year, Mangels revenue was $204M and Mangels EBITDA was $25M.

Mangels Overview

About Mangels

Mangels Industrial SA produces, markets, sells and distributes steel and related products. It operates in four segments, Steel, Wheel, Cylinder and Galvanizing. It supplies wheels to the car industry, motorcycles, trucks, buses, appliances, and gas companies; liquefied petroleum gas cylinders; air tanks for heavy vehicles, agricultural machinery, and air compressors; rear axles for light vehicles; and rolls, blanks, and sheets of low carbon and high strength steel for use in motorcycles, electronics and accessories, and hardware components.


Founded

1928

HQ

Brazil

Employees

N/A

Financials (Last FY)

Revenue: $204M
EBITDA: $25M

EV

$133M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Mangels Financials

Mangels reported last fiscal year revenue of $204M and EBITDA of $25M.

In the same fiscal year, Mangels generated $26M in gross profit, $25M in EBITDA, and $9M in net income.


Mangels P&L

In the most recent fiscal year, Mangels reported revenue of $204M and EBITDA of $25M.

Mangels is profitable as of last fiscal year, with gross margin of 13%, EBITDA margin of 12%, and net margin of 5%.

See analyst estimates for Mangels
Last FY202320242025202620272028
Revenue$204M$182M$186M$204M
Gross Profit$26M$25M$22M$26M
Gross Margin13%14%12%13%
EBITDA$25M$25M$2M$25M
EBITDA Margin12%14%1%12%
EBIT Margin7%9%6%7%
Net Profit$9M$7M($8M)$9M
Net Margin5%4%(4%)5%
Net Debt$97M---

Financial data powered by Morningstar, Inc.

Mangels Stock Performance

Mangels has current market cap of $4M, and enterprise value of $133M.

Market Cap Evolution


Mangels' stock price is $1.05.

Mangels share price decreased by 13.3% in the last year.

Mangels has an EPS (earnings per share) of $2.48.

See more trading valuation data for Mangels
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$133M$4M0.0%-1.0%-13.3%$2.48

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Mangels Valuation Multiples

Mangels trades at 0.7x EV/Revenue multiple, and 5.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Mangels

Mangels Financial Valuation Multiples

As of October 3, 2026, Mangels has market cap of $4M and EV of $133M.

Mangels has a P/E ratio of 0.4x.

Last FY202320242025202620272028
EV/Revenue0.7x0.7x0.7x0.7x
EV/EBITDA5.3x5.3x80.0x5.3x
EV/EBIT8.7x8.1x11.4x8.7x
EV/Gross Profit5.1x5.3x6.0x5.1x
P/E0.4x0.6x(0.5x)0.4x
EV/FCF17.1x12.9x9.6x17.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Mangels Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Mangels Margins & Growth Rates

In the most recent fiscal year, Mangels reported gross margin of 13%, EBITDA margin of 12%, and net margin of 5%.

See estimated margins and future growth rates for Mangels

Mangels Margins

Last FY20242025202720282029
Gross Margin13%12%13%
EBITDA Margin12%1%12%
EBIT Margin7%6%7%
Net Margin5%(4%)5%
FCF Margin4%7%4%

Mangels Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth2%10%
Gross Profit Growth(11%)17%
EBITDA Growth(93%)1410%
EBIT Growth(29%)30%
Net Profit Growth(222%)(213%)
FCF Growth34%(44%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Mangels Operational KPIs

Access forward-looking KPIs for Mangels
Last FY202320242025202620272028
S&M Expenses to Revenue1%1%1%1%
G&A Expenses to Revenue4%4%4%4%
Opex to Revenue5%5%6%5%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Bubalus Resources------
Galvo$6M$260K0.7x-15.8x-
EKOPOL Gornoslaski Holding$59M$775K0.0x-1.9x-
Lovisagruvan$2M$689K3.0x-8.1x-
Cross River Ventures------
Winshear Gold-($1M)--(2.0x)-
Liberti Skopje$94M($5M)0.0x-(0.7x)-
Leventeris------

This data is available for Pro users. Sign up to see all Mangels competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Mangels

When was Mangels founded?Mangels was founded in 1928.
Where is Mangels headquartered?Mangels is headquartered in Brazil.
Is Mangels publicly listed?Yes, Mangels is a public company listed on B3.
What is the stock symbol of Mangels?Mangels trades under MGEL3 ticker.
When did Mangels go public?Mangels went public in 2004.
Who are competitors of Mangels?Mangels main competitors include Bubalus Resources, Galvo, EKOPOL Gornoslaski Holding, Lovisagruvan, Cross River Ventures, Winshear Gold, Liberti Skopje, Leventeris, Premier African Minerals, Golden Age Exploration.
What is the current market cap of Mangels?Mangels' current market cap is $4M.
What is the current revenue of Mangels?Mangels' last fiscal year revenue is $204M.
What is the current EV/Revenue multiple of Mangels?Current revenue multiple of Mangels is 0.7x.
Is Mangels profitable?No, Mangels is not profitable.
How many companies Mangels has acquired to date?Mangels hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Mangels has invested to date?Mangels hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Mangels

Lists including Mangels

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial